← FDA DRUG APPROVALS

FDA ANDA · ANDA076336

MIRTAZAPINE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA076336
TYPE
ANDA
ORIGINAL APPROVAL
2003-06-20
LATEST ACTION
2007-11-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MIRTAZAPINEDiscontinued
MIRTAZAPINE 30MG · TABLET · ORAL
MIRTAZAPINEDiscontinued
MIRTAZAPINE 45MG · TABLET · ORAL
MIRTAZAPINEDiscontinued
MIRTAZAPINE 15MG · TABLET · ORAL

Approval history

2007-11-05Labeling · Supplement 7AP
2006-11-06Labeling · Supplement 6AP
2005-04-28Labeling · Supplement 5AP
2005-04-28Labeling · Supplement 3AP
2003-06-20Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →